| Home | E-Submission | Sitemap | Editorial Office
top_img
    
REVIEW
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
Medical imaging plays an important role in the diagnosis and management of hepatocellular carcinoma (HCC). The Liver Imaging Reporting and Data System (LI-RADS) was initially created to standardize the reporting and data collection of CT and MR imaging for patients at risk for H...
REVIEW
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Non-alcoholic fatty liver disease (NAFLD) has been an emerging major health problem, and the most common cause of chronic liver disease in Western countries. Traditionally, liver biopsy has been gold standard method for quantification of hepatic steatosis. However, its invasive ...
REVIEW
Histopathological evaluation of liver fibrosis and cirrhosis regression
The hepatic repair complex in the setting of cirrhosis has received increasing attention, as it implies the regression of cirrhosis, which was traditionally taken to be an irreversible state. In this brief review, the patterns of fibrosis, the existing staging systems for chroni...
ORIGINAL ARTICLE
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Background/Aims: Treatment of chronic hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) is essential. The availability of sofosbuvir (SOF) has dramatically improved overall HCV cure rates, however there is insufficient data regarding its use in pati...
Current Issue
Volume 23(4); Dec 2017
Volume 23(3); September 2017
Volume 23(2); June 2017
Volume 23(1); March 2017
Volume 22(4); December 2016
RSS feed
  • Most-cited are based on citations from 2016 ~ 2018.

    KASL clinical practice guidelines: management of chronic hepatitis B
    Clin Mol Hepatol.2016;22(1):18-75.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.18
                                     Cited By 40
    A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
    Su Jong Yu
    Clin Mol Hepatol.2016;22(1):7-17.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.7
                                     Cited By 38
    KASL clinical practice guidelines: management of hepatitis C
    The Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol.2016;22(1):76-139.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.76
                                     Cited By 13
    The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
    Goh Eun Chung, Donghee Kim, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Seon Hee Lim, Mustafa Itani
    Clin Mol Hepatol.2016;22(1):146-151.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.146
                                     Cited By 12
    Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
    Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee
    Clin Mol Hepatol.2016;22(1):160-167.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.160
                                     Cited By 11
    Genetic predisposition in nonalcoholic fatty liver disease
    Silvia Sookoian, Carlos J. Pirola
    Clin Mol Hepatol.2017;23(1):1-12.   Published online March 9, 2017     
    DOI: https://doi.org/10.3350/cmh.2016.0109
                                     Cited By 11
    Current status of laparoscopic liver resection for hepatocellular carcinoma
    Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy
    Clin Mol Hepatol.2016;22(2):212-218.   Published online June 15, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0026
                                     Cited By 10
    Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
    Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
    Clin Mol Hepatol.2016;22(3):327-335.   Published online September 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0049
                                     Cited By 9
    Acute-on-chronic liver failure: a new syndrome in cirrhosis
    Richard Moreau
    Clin Mol Hepatol.2016;22(1):1-6.   Published online March 28, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.22.1.1
                                     Cited By 8
    Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
    Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim
    Clin Mol Hepatol.2016;22(2):296-307.   Published online June 15, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0028
                                     Cited By 8
    The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
    Ioannis Varbobitis, George V. Papatheodoridis
    Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0045
                                     Cited By 7
    What we need to know when performing and interpreting US elastography
    So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
    Clin Mol Hepatol.2016;22(3):406-414.   Published online September 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0106
                                     Cited By 7
    Acute kidney injury in liver cirrhosis: new definition and application
    Florence Wong
    Clin Mol Hepatol.2016;22(4):415-422.   Published online December 14, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0056
                                     Cited By 7
    Management of direct antiviral agent failures
    María Buti, Rafael Esteban
    Clin Mol Hepatol.2016;22(4):432-438.   Published online December 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0107
                                     Cited By 7
    Liver transplantation for advanced hepatocellular carcinoma
    Hae Won Lee, Kyung-Suk Suh
    Clin Mol Hepatol.2016;22(3):309-318.   Published online September 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0042
                                     Cited By 6
    Prevention of Hepatitis B reactivation in the setting of immunosuppression
    Venessa Pattullo
    Clin Mol Hepatol.2016;22(2):219-237.   Published online June 13, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0024
                                     Cited By 5
    Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
    Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Clin Mol Hepatol.2016;22(2):250-258.   Published online June 25, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0015
                                     Cited By 5
    Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
    Gaeun Kim, Moon Young Kim, Soon Koo Baik
    Clin Mol Hepatol.2017;23(1):34-41.   Published online March 7, 2017     
    DOI: https://doi.org/10.3350/cmh.2016.0059
                                     Cited By 5
    Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
    Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso
    Clin Mol Hepatol.2016;22(2):199-211.   Published online May 18, 2016     
    DOI: https://doi.org/10.3350/cmh.2016.0101
                                     Cited By 4
    Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
    Seung Woon Park, Soon Ho Um, Han Ah Lee, Sang Hyun Kim, Yura Sim, Sun Young Yim, Yeon Seok Seo, Ho Sang Ryu
    Clin Mol Hepatol.2016;22(2):281-285.   Published online June 1, 2016     
    DOI: https://doi.org/10.3350/cmh.2015.0040
                                     Cited By 4
  • Editorial Office
    The Korean Association for the Study of the Liver
    Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
    TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © The Korean Association for the Study of the Liver. All rights reserved.